Fangfang Tao
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 6
- MicroRNA in disease regulation 4
- Modeling and Simulation top 10%
-
- Antibiotic Resistance in Bacteria 4
-
- SARS-CoV-2 and COVID-19 Research 3
-
- Vaccine Coverage and Hesitancy 3
-
- Cancer Mechanisms and Therapy 5
-
- Circular RNAs in diseases 5
- Bacterial biofilms and quorum sensing 3
- Co-authors
- Zhiqian ZhangXinxin TianMinhe ShenShanming RuanWenhong LiuBaotong ZhangXiawei JiangJin‐Tang Dong
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Fangfang Tao
38 papers receiving 498 citations
Peers
Comparison fields: 5 of 107
- Cancer Research 178
- Modeling and Simulation 26
- Molecular Medicine 28
- Infectious Diseases 76
- Health 33
Countries citing papers authored by Fangfang Tao
This map shows the geographic impact of Fangfang Tao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangfang Tao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangfang Tao more than expected).
Fields of papers citing papers by Fangfang Tao
This network shows the impact of papers produced by Fangfang Tao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangfang Tao. The network helps show where Fangfang Tao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fangfang Tao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 3 | |
| 4 | 2025 | 6 | |
| 5 | 2025 | 1 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 2 | |
| 9 | 2024 | 5 | |
| 10 | 2023 | 7 | |
| 11 | 2023 | 0 | |
| 12 | 2023 | 15 | |
| 13 | 2022 | 56 | |
| 14 | 2018 | 11 | |
| 15 | 2018 | 47 | |
| 16 | 2017 | 17 | |
| 17 | 2016 | 18 | |
| 18 | 2013 | 37 | |
| 19 | Expression of NGX6 and Cyclin D1 in gastric carcinoma and its clinical significance | 2012 | 1 |
| 20 | Immunological identification of Th1-type epitope in tegumental membrane-associated antigen Sj22.6 of Schistosoma japonicum. | 2009 | 1 |
About Fangfang Tao
Fangfang Tao is a scholar working on Molecular Medicine, Cancer Research and Modeling and Simulation, having authored 41 papers that have together received 506 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), Cancer Mechanisms and Therapy (5 papers), Circular RNAs in diseases (5 papers), MicroRNA in disease regulation (4 papers), Antibiotic Resistance in Bacteria (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Bacterial biofilms and quorum sensing (3 papers) and Vaccine Coverage and Hesitancy (3 papers). The work is most often cited by research in Cancer Research (178 citations), Modeling and Simulation (26 citations) and Molecular Medicine (28 citations). Fangfang Tao has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Zhiqian Zhang, Xinxin Tian, Minhe Shen, Shanming Ruan, Wenhong Liu, Baotong Zhang, Xiawei Jiang, Jin‐Tang Dong, Yanrong Zhang and Zhi Li. Their work appears in journals such as Nature Communications, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.